Journals / TSK Koruyucu Hekimlik Bülteni / 2010 / Cilt: 9 - Sayı: 2

Akciğer tüberkülozlu hastaların kardiyovasküler sağlıklarının, altı dakikalık yürüme testi kullanılarak değerlendirilmesi

Assessment of cardiovascular fitness of patients with pulmonary tuberculosis using six minute walk test

Pages
99–106
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The 6-MWT may be useful in the assessment of functional capacity of patients with pulmonary TB.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Patients with pulmonary tuberculosis (TB) tends to have limited exercise tolerance and a significant disability affecting their activities of daily living.
📊
Key Findings & Data:This study was designed to assess the cardiovascular fitness of patients with pulmonary TB using the six-minute walk test (6-MWT).
💡
Conclusion & Impact:The 6-MWT may be useful in the assessment of functional capacity of patients with pulmonary TB.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: Patients with pulmonary tuberculosis (TB) tends to have limited exercise tolerance and a significant disability affecting their activities of daily living. The importance of exercise in the management of these patients has not been well investigated. This study was designed to assess the cardiovascular fitness of patients with pulmonary TB using the six-minute walk test (6-MWT). METHOD: Sixty five consented patients with Pulmonary TB were consecutively recruited into the study. The patients performed 6-MWT over a 30 meter course on a level walkway at a speed as fast as they could. Data were obtained on participants’ physical characteristics, pre and post exercise blood pressure and heart rate, and maximum oxygen consumption. Data were analyzed using descriptive statistics of mean and standard deviation and paired t-test. RESULTS: The post walk test cardiovascular parameters were significantly higher than the resting cardiovascular parameters. The mean VO2 max and MET of the participants were 11.7±0.97 (ml O2kg -1min-1) and 3.35±0.28 (mL/Kg) respectively. The means 6-MWT distance for male and female participants were 502.0±43.0m 481.7±68.3m respectively. CONCLUSION: The result implies that the 6-MWT is capable of evoking a significant cardiovascular change among patients with pulmonary TB. The 6-MWT may be useful in the assessment of functional capacity of patients with pulmonary TB.

Özet

AMAÇ: Akciğer tüberkülozu hastaları, azalmış egzersiz toleransı ve günlük yaşamsal aktivitelerini gerçekleştirmede yetersizlik yaşamaktadırlar. Bu hastalar incelenirken egzersizin önemi yeterince araştırılmamıştır. Bu çalışma, akciğer tüberkülozlu hastalarinin alti dakikalik yürüme testi (6-MWT) kullanilarak kardiyovasküler sağlıklarının değerlendirilmesi amacıyla gerçekleştirilmiştir. YÖNTEM: Altmış beş gönüllü akciğer tüberkülozu hastası çalışmaya dahil edilmiştir. Katılımcılar, 6-MWT testini 30 metrelik yürüme parkurunda yapabildikleri kadar hızlı yürüyerek uygulamışlardır. Katılımcılardan toplanan veriler; fiziksel karakteristikleri, egzersiz öncesi-sonrası kan basıncı ve kalp hızı ölçümleri ve maksimum oksijen tüketimi şeklindedir. Elde edilen bulgular, tanımlayıcı analizler, ortalama ve standart sapma ve bağımlı gruplarda t testi kullanılarak analiz edilmiştir. BULGULAR: Yürüyüş sonu kardiyovasküler bulguların dinlenme sırasındaki bulgulardan anlamlı bir şekilde yüksek oldukları bulunmuştur. Ortalama VO2 max ve katılımcıların MET değerleri sırasıyla; 11,7±0,97 (ml O2kg -1min-1) ve 3,35±0,28 (mL/Kg). Ortalama 6-MWT uzaklığı erkeklerde ve kadın katılımcılarda sırasıyla, 502.0±43.0 m. ve 481.7±68.3 m. bulunmuştur. SONUÇ: 6-MWT testi sonuçlarına gore, akciğer tüberkülozu hastalarında anlamlı kardiyovasküler değişimler olduğu değerlendirilmiştir. 6-MWT testi akciğer tüberkülozu hastaların fonksiyonel kapasitelerini değerlendirmek açısından kullanışlı olabilir.

🔖

Cite This Article

ADEDOYIN, R. A., ERHABOR, G. E., OJO, O. D., MBADA, C. E., AWOTIDEBE, T. O., OBASEKI, D. O., AWOFOLU, O. O. (2010). Akciğer tüberkülozlu hastaların kardiyovasküler sağlıklarının, altı dakikalık yürüme testi kullanılarak değerlendirilmesi. TSK Koruyucu Hekimlik Bülteni, Cilt: 9 - Sayı: 2, 99–106. https://ajindex.com/articles/130545

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Loachimescu O, Tomford JW. 2004. Tuberculosis._The_Cleveland_clinic._www.clevel andclinicmeded.com/medicalpubs/diseasemanag ement/pulmonary/tb/tb.htm. [Accessed date 05.08.2008]
  2. World Health Organization (WHO). WHO/ Tuberculosis: Infection and transmission. Fact sheet N 140, revised. 2005
  3. Igbuzor EJ. Phage amplification technology in the disease of pulmonary tuberculosis. Applicability in Nigeria. Afr J Clinical and Experimental Microbiology. 2002; 3(2): 55-63
  4. World Health Organization (WHO). Global Report: Global Tuberculosis Control. WHO Report. 2006
  5. Salami AK, Oluboyo PO. Hospital prevalence of pulmonary tuberculosis and co-infection with human immunodeficiency virus in Ilorin; a review of nine years 1991–1999. West Afr J Med. 2002; 21(1): 24–27
  6. James L, Diana B. 2006 Tuberculosis. www.emedicine.com/emerg/topic618. [Accessed date 05.08.2008]
  7. Comstock GW. Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol. 1975; 5: 363–382
  8. Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc Lung Dis. 1975; 5: 90–106
  9. Styblo K. State of the art: epidemiology of tuberculosis. Bull Int Union Tuberc. 1978; 53: 141–152
  10. Elegbe IA, Salawu L, Adeyemo AO. Pulmonary Tuberculosis in Nigeria. The Journal of the Royal Society for the Promotion of Health. 1986; 6(2): 69-71
  11. Murray CJ, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis. 1990; 65: 6– 24
  12. Smith PG. Epidemiology of tuberculosis. In: Bloom B, ed. Tuberculosis: pathogenesis, protection and control. Washington, DC. American Society for Microbiology, 1994, p. 13- 24
  13. Lienhardt C, Bennett S, Del Prete G, Bah-Sow O, Newport M, Gustafson P, at al. Investigation of Environmental and Host-related Risk Factors for Tuberculosis in Africa. I. Methodological Aspects of a Combined Design. Am J. Epidemiol. 2002; 155(11): 1066-1073
  14. Enwuru CA, Idigbe EO, Ezeobi NV, Otegbeye AF. Care-seeking behavioural patterns, awareness and diagnostic processes in patients with smearand culture-positive pulmonary tuberculosis in Lagos, Nigeria. Trans R Soc Trop Med Hyg. 2002; 96: 614–616
  15. Needham DM, Godfrey-Faussett P, Foster SD. Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis. 1998; 2: 811– 817
  16. Odusanya OO, Babafemi. JO. Patterns of delays amongst pulmon